| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |